星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2024-07-09 ZeBoJiang 来自广东省

审稿速度:6.0
经验分享：投稿几个月了还不会意见

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2023-07-30 ms9000001459812965 来自陕西省

偏重的研究方向：药理活性
经验分享：有大佬分享一下投稿进程嘛

94 0

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2023-07-30 ms9000001459812965 来自陕西省

偏重的研究方向：药理活性
经验分享：有大佬投过这个杂志吗。能否给个进度流程呀

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2021-12-28 MS54455111222

如何评估自身文章的IF，或者说如何更好地定位自己的文章？

85 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2021-12-28 小动量

选刊时选择几个比较合适？

87 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2020-03-02 墨菲的菲

请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表::
研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表:
2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。

kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。

173 0

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2018-03-09 小蚂蚁1717

状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆

372 0

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2017-10-09 学术查

一个月左右，状态为 awaiting reviewer score

397 0

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2017-09-20 kobe24song

审稿速度:2.0 | 投稿命中率:75.0
经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。

393 0

[GetPortalCommentsPageByObjectIdResponse(id=2214018, encodeId=a88d2214018df, content=审稿速度:6.0 经验分享：投稿几个月了还不会意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45525539852, createdName=ZeBoJiang, createdTime=Tue Jul 09 09:11:39 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150490, encodeId=cdfb215049077, content=偏重的研究方向：药理活性 经验分享：有大佬分享一下投稿进程嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 10:27:46 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150511, encodeId=9661215051164, content=偏重的研究方向：药理活性 经验分享：有大佬投过这个杂志吗。能否给个进度流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78a86574728, createdName=ms9000001459812965, createdTime=Sun Jul 30 15:38:03 CST 2023, time=2023-07-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088578, encodeId=f03410885e883, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088577, encodeId=d1a210885e7b9, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585743, encodeId=5501585e4353, content=请问一共是几个审稿人意见呢？kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。kobe24song 2017-09-20 01:26:00 发表: 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=kobe24song 2017-09-20 发表:: 研究方向：药物化学;植物化学;药理活性接收率：约75% 审稿时间：约2个月 2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vtziaCEBh36dvVEBQr7IRoO6ReMrzocpqZHMY3677Q2I93hTuI1CpRRQG3ZLZYgsWG97ibmbSoTQzp8rVfkqYTZA/132, createdBy=7e3f5092430, createdName=墨菲的菲, createdTime=Mon Mar 02 00:00:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553457, encodeId=4d6855345e56, content=状态一直是Awaiting SE Assignment 有类似的同学么，是不是被拒的前兆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dce1964605, createdName=小蚂蚁1717, createdTime=Fri Mar 09 08:34:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548022, encodeId=a551548022e7, content=一个月左右，状态为 awaiting reviewer score, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Mon Oct 09 08:55:00 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547410, encodeId=e1a754e410bd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2016年投过一篇，两个月左右收到意见，给的小修，小修后接收。貌似是7页以内不收钱，超过一页100美金一页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Wed Sep 20 01:26:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547303, encodeId=e36854e3036b, content=投稿一周了，状态还是awaiting SE assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a72083471, createdName=学术查, createdTime=Sun Sep 17 21:07:00 CST 2017, time=2017-09-17, status=1, ipAttribution=)]

2017-09-17 学术查

投稿一周了，状态还是awaiting SE assignment

367 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务